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Abstract
Propolis is a resin formed by a complex chemical composition of substances that bees collect from plants. Since an-
cient times, propolis has been used in folk medicine, due to its biological properties, that include antimicrobial,
anti-inflammatory, antitumoral and immunomodulatory activities. Glioblastoma is the most common human brain tu-
mor. Despite the improvements in GBM standard treatment, patients' prognosis is still very poor. The aim of this work
was to evaluate in vitro the Tubi-bee propolis effects on human glioblastoma (U251 and U343) and fibroblast
(MRC-5) cell lines. Proliferation, clonogenic capacity and apoptosis were analyzed after treatment with 1 mg/mL and
2 mg/mL propolis concentrations for different time periods. Additionally, glioblastoma cell lines were submitted to
treatment with propolis combined with temozolomide (TMZ). Data showed an antiproliferative effect of tubi-bee
propolis against glioblastoma and fibroblast cell lines. Combination of propolis with TMZ had a synergic anti-
proliferative effect. Moreover, propolis caused decrease in colony formation in glioblastoma cell lines. Propolis treat-
ment had no effects on apoptosis, demonstrating a cytostatic action. Further investigations are needed to elucidate
the molecular mechanism of the antitumor effect of propolis, and the study of its individual components may reveal
specific molecules with antiproliferative capacity.
Key words: glioblastoma, propolis, temozolomide, U251, U343.
Received: August 6, 2010; Accepted: February 4, 2011.
Propolis is a resinous product composed of various
botanical exudates, collected from plants and used by bees
as a protective hive barrier against different pathogens. Its
chemical composition includes flavonoids, aromatic acids,
esters, aldehydes, ketones, fatty acids, terpenes, steroids,
amino acids, polysaccharides, hydrocarbons, alcohols, hy-
droxybenzene, and several other compounds in trace
amounts (Bankova et al., 1983; Marcucci, 1995). Its com-
position varies according to the resin sources in the hive
specific region. Propolis has been widely used in folk medi-
cine, with therapeutic or preventive effects against inflam-
mation, heart disease, diabetes mellitus, microbial hepa-
totoxicity and cancer (Bankova et al., 1998; Burdock,
1998).
Glioblastoma is the most frequent and aggressive pri-
mary brain tumor in adults. Despite standard treatments,
consisting of surgery and postoperative radiotherapy, pa-
tient survival remains poor, mainly attributed to tumor-
inherent radio- and chemoresistance (Esteller et al., 2000;
Scrideli et al., 2008). In recent years, the combination of the
alkylating agent temozolomide (TMZ) with standard daily
fractionated irradiation therapy followed by adjuvant TMZ
have shown to improve prognosis, therefore becoming a
part of the standard therapy for patients with newly diag-
nosed glioblastoma (van Nifterik et al. 2007; Brandes et al.,
2010). This chemotherapeutic pro-drug is transformed un-
der physiological conditions into its active unstable methy-
lating metabolite, 5-(3-methyl-1-triazeno)imidazole-4-car-
boxamide (MTIC). Methylation of the DNA by MTIC
results in O6-methylguanine adducts, which are considered
to be responsible for the cytotoxic effect of TMZ (Esteller
et al., 2000; Brandes et al., 2010). O6-methylguanine ad-
ducts can result in futile attempts of the mismatch repair
system, leading to DNA double-strand breakage and even-
tually cell death (van Nifterik et al., 2007)
Several reports have shown the antiproliferative ef-
fects of propolis from different origins and their fractions in
several cancer cell lines (Grunberger et al., 1988; Khalil,
2006). In the present study, we describe the anti-cancer ef-
fects of ethanolic propolis extract produced by
Scaptotrigona sp (Tubi-bee propolis) in glioblastoma cell
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lines, associated or not with TMZ, and in one non-neo-
plastic fibroblast cell line.
Propolis samples obtained from the stingless “Tubi”
beehives (Scaptotrigona sp) were collected in the Serra do
Corda region (Maranhão State, Brazil). Tubi-bee propolis
extracts were obtained as previously described (Farnesi et
al., 2009). Briefly, propolis was ground and an ethanol ex-
tract was prepared, as follows: 30 g of propolis/100 mL eth-
anol (70%). The solution was kept at room temperature for
20 days and shaken once a day. After filtration, the solvent
was totally evaporated in a water bath, at temperatures not
exceeding 50 °C. For cell assays the crude extract was di-
luted in dimethylsulphoxide (DMSO, Sigma-Aldrich).
TMZ, known commercially as Temodal®, was ac-
quired from Schering-Plough Brazil and diluted according
to the manufacturer's instructions. The capsule content was
diluted in water at a ratio of 22 mg drug/100 mL water. This
solution was placed in a shaker for 30 min at 37 °C and then
filtered through a Millipore® filter (0.5 m). By this proce-
dure, 85% of dissolved active principle was obtained.
Aliquots of the drug were stored at -20 °C. TMZ concentra-
tions of 20, 50 and 100 M were used in the experiments.
Human adult glioblastoma cell lines U251 and U343
and the human fibroblast cell line MRC5 were purchased
from the American Type Culture Collection. Cells were
cultured in HAM F10 medium (Gibco BRL, Life Technol-
ogies®, Carlsbad, CA, USA) supplemented with 10% fetal
bovine serum, penicillin (100 U/mL) and streptomycin
(100 g/mL), at 37 °C in a humidified 5% CO2 incubator.
The effects of propolis on clonogenic capacity were
evaluated by a clonogenic assay (Franken et al., 2006). Af-
ter trypsinization, single cell suspensions of 300 cells were
seeded into 6-well plates and treated with propolis extract
at the concentrations of 1 and 2 mg/mL for 48 h. After this
treatment, the culture medium was removed and replaced
with extract-free medium. The cell cultures were then incu-
bated for 7-10 days and thereafter the colonies were rinsed
with PBS, fixed with methanol and stained with Giemsa.
All colonies with > 50 cells were counted. Assays were per-
formed in triplicate.
For the proliferation assay, cells were seeded on 96-
well plates (1x103 cells/well). After 24 h, the medium was
replaced with fresh media containing the treatment (pro-
polis, TMZ or DMSO at 0,5%) and then cultured for 24, 48
and 72 h. After the treatment, the culture medium was re-
moved and replaced with medium containing 10 L of XTT
dye (3 mg/mL) (XTT II; Roche Molecular Biochemicals,
Indianapolis, USA) in each well. The plates were incubated
for 2 h at 37 °C, and the formazan product was measured at
450 nm in an iMark microplate reader (Bio-Rad Labora-
tories). All experiments were performed in triplicate. Va-
lues are shown as mean  SD.
For apoptosis assessment, a total of 3x105 cells were
seeded in 25 cm2 tissue culture flasks containing 5 mL of
culture medium. After 24 h, the medium was replaced,
propolis and DMSO were added, and then the cells were
cultured for additional 48 h. Apoptotic cells were recog-
nized by nuclear condensation and fragmentation, accord-
ing to Lee and Shacter (1999). Treated cells were centri-
fuged and incubated for 5 min at 37 °C with bisbenzimide
(Hoechst 33342), propidium iodide and fluorescein dia-
cetate (Sigma Chemical Co., St. Louis, USA). Then, sam-
ples were mounted on slides, coverslipped and analyzed by
fluorescence microscopy with a triple filter. Cells were
scored and categorized according to differential staining:
(1) normal: blue nucleus and green cytoplasm, (2) apo-
ptotic: fragmented blue nucleus and green cytoplasm, and
(3) necrotic: spherical red nucleus. 500 nuclei were ana-
lyzed per treatment.
One-way or two-way ANOVA followed by the ap-
propriate post-hoc test (Bonferroni) were used to check for
significant differences between groups (differences be-
tween doses or times). Differences were considered signifi-
cant at p < 0.05.
To determine the TMZ concentration for combination
with propolis, U343 and U251 cells were submitted to dif-
ferent concentrations of TMZ for 24, 48 and 72 h. The TMZ
concentration chosen for combined treatment was 50 M,
which reduced proliferation at 48 h for U251 and U343 cell
lines (Figure 2).
U251, U343 and MCR-5 cell lines were treated with
propolis extract at the concentrations of 1 and 2 mg/mL for
24, 48 and 72 h. The glioblastoma cell lines were also
treated with a propolis concentration of 2 mg/mL associ-
ated with 50 M of temozolomide. Cell viability was deter-
mined by an XTT assay, as described above.
Propolis extract concentrations inhibited growth of
the three cell lines when compared with DMSO (0.5%)
(p < 0.05) (Figure 1). For cell line U251, proliferation inhi-
bition was observed at 24, 48 and 72 h corresponding to a
10, 24 and 46% decrease with the 1 mg/mL dose, and a 15,
32 and 59% decrease with the 2 mg/mL dose, respectively.
However, there was no statistically significant difference
between the concentrations for this cell line at the times
studied (Figure 1A).
In cell line U343, a decrease in proliferation was ob-
served at 24, 48 and 72 h for both dosages, corresponding to
a 14, 21 and 30% decrease for the 1 mg/mL, and a 30, 42
and 48% decrease for the 2 mg/mL dose. For this cell line,
all treatments except the 72 h treatment showed statistically
significant differences between the concentrations (Fig-
ure 1B).
Statistically significant effects of dose and time de-
pendence were observed only for the U343 cell line
(p < 0.05). The association of propolis and TMZ showed a
synergistic effect on both glioblastoma cell lines at all times
analyzed, except for the U343 cell line at 72 h (Figure 1A
and B). In the fibroblast MRC-5 cell line a decrease in pro-
liferation was also observed, although this effect was nei-
ther dose- nor time-dependent (Figure 1C).
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In both the U251 and U343 cell lines treated with 1
and 2 mg/mL propolis extract for 48 h, a decrease in colony
formation capacity was observed; however, there was no
difference between the two treatments (data not shown).
To determine the occurrence of apoptosis in GBM
cells treated with the propolis extract, the cells were differ-
entially stained. Apoptosis was not observed after the treat-
ment with propolis at neither of the concentrations tested.
The methodology applied also allowed the detection of ne-
crotic cells, observed at a low number and without differ-
ences between treatments (data not shown).
Propolis, a complex mixture of plant metabolites,
shows a broad spectrum of biological activities including
antibiotic, antioxidative, anti-inflammatory and anticancer
effects (Bankova et al., 1983; Marcucci, 1995; Banskota et
al., 2001). Its cytotoxicity in cultures of human and animal
tumor cells, including breast carcinoma, melanoma, colon
and renal carcinoma cell lines, has been frequently reported
in the literature (Khalil, 2006).
The present study showed that propolis extract inhib-
ited proliferation in glioblastoma and fibroblast cell lines,
as already demonstrated by previous studies. Propolis ex-
tract from the Netherlands showed an interesting antiproli-
ferative activity against highly metastatic liver murine
colon 26-L5 carcinoma cells (Banskota et al., 2000). A
butanolic Greek propolis extract was also found to be cyto-
toxic in two malignant human cell lines (HT-1080 fibro-
sarcoma and HT-29 colon adenocarcinoma), whereas it
was not equally toxic when tested in normal human skin
fibroblasts (Pratsinis et al., 2010).
In cell line U343, the antiproliferative effect of pro-
polis was dose- and time-dependent, suggesting that this
cell line is more sensitive than U251 that did not present the
same effect. These differences could be associated with p53
status (mutant or wild type). Cell line U343, but not U251,
carries the wild type gene (Ishii et al., 1999) and the anti-
proliferative effects of propolis may be p53-dependent.
Other studies have shown increased expression of p53 after
treatment with different propolis extracts (Weng et al.,
2007; Ishihara et al., 2009; Xuan et al., 2010). Several func-
tions and activities are attributed to p53, and it also acts in
different cellular metabolism processes, such as cell cycle,
apoptosis, senescence and DNA repair (Joerger and Fersht,
2008).
The combination of propolis with temozolomide, a
chemoterapeutic drug used in the treatment of glioblastoma
which produces DNA alkylation (Esteller et al., 2000), evi-
denced synergistic antiproliferative effects, demonstrating
the ability of propolis to predispose cells to the action of
chemotherapy (Figures 1A and B). However, this effect
should be further investigated.
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Figure 2 - Proliferation assay of cell lines treated with TMZ at the concen-
trations of 20, 50 and 100 M, for 24, 48 and 72 h. Asterisks indicates a
statistically significant difference between the TMZ-treated and the con-
trol group.Figure 1 - Proliferation assay of cell lines treated with Tubi-bee propolis
at the concentrations of 1 and 2 mg/mL for 24, 48 and 72 h. Glioblastoma
cells were also treated with temozolomide (TMZ) combined with propolis.
Asterisks indicate a statistically significant difference between groups. A.
U251, B. U343, C. MRC5.
The effects observed in this work can be related with
the chemical composition of propolis, which is highly de-
pendent on the flora of the region where it is collected.
Sawaya et al. (2009) studied the same Tubi-bee propolis
used in this work and showed that its composition varied
seasonally. The mass spectra ions found in this extract were
m/z 371, 373, 401 and 471. This latter was the more impor-
tant one; its formula C30H47O4 suggests that it has at least
one acid function. Electrospray Ionization – Mass Spec-
trometry (ESI-MS) of these ions showed to be compatible
with terpenes and with acid groups. All are marker ions of
Schinus terebenthifolius, also known in Brazil as “aroeira
mansa”, a preferred source of resins in stingless bee pro-
polis in many regions of Brazil.
Propolis from temperate zones predominantly con-
tains phenolic compounds, including flavonoids and cin-
namic acid derivatives (Marcucci, 1995). On the other
hand, diterpenes and prenylated compounds, which are vir-
tually absent in propolis from temperate zones, have been
reported to be the major constituents of propolis from tropi-
cal South America, along with lignans, flavonoids and
other classes of compounds (Sawaya et al., 2009).
Several reports have shown apoptosis induction cau-
sed by propolis extracts (Weng et al., 2007; Szliszka et al.,
2009; Xuan et al., 2010). However, in the present study,
this effect was not observed, suggesting that in the concen-
trations used this type of propolis presents only cytostatic
effects.
In summary, this investigation of the potential anti-
proliferative effects of propolis in human glioblastoma and
normal fibroblast cell lines showed a strong inhibitory ef-
fect on the proliferation of all cell lines tested. Dose and
time dependence were only observed for cell line U343.
Moreover, the association of propolis with temozolomide
produced synergistic antiproliferative effects. Propolis
treatment also inhibited the clonogenic capacity in GBM
cell lines, but the antitumor effects observed here were not
caused by apoptosis. Further investigations are needed to
elucidate the molecular mechanism of the antitumor effect
of propolis, and the study of its individual constituents may
reveal specific molecules with antiproliferative capacity.
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